Canada markets open in 15 minutes

Ono Pharmaceutical Co., Ltd. (4528.T)

Tokyo - Tokyo Delayed Price. Currency in JPY
Add to watchlist
2,232.50+11.50 (+0.52%)
At close: 03:15PM JST
Currency in JPY

Valuation Measures4

Market Cap (intraday) 1.04T
Enterprise Value 847.35B
Trailing P/E 8.33
Forward P/E 13.95
PEG Ratio (5 yr expected) N/A
Price/Sales (ttm)2.12
Price/Book (mrq)1.32
Enterprise Value/Revenue 1.69
Enterprise Value/EBITDA 4.65

Trading Information

Stock Price History

Beta (5Y Monthly) 0.17
52-Week Change 3-13.95%
S&P500 52-Week Change 323.12%
52 Week High 32,966.50
52 Week Low 32,097.50
50-Day Moving Average 32,240.28
200-Day Moving Average 32,505.93

Share Statistics

Avg Vol (3 month) 32.1M
Avg Vol (10 day) 31.76M
Shares Outstanding 5469.65M
Implied Shares Outstanding 6474.03M
Float 8383.27M
% Held by Insiders 115.55%
% Held by Institutions 147.30%
Shares Short 4N/A
Short Ratio 4N/A
Short % of Float 4N/A
Short % of Shares Outstanding 4N/A
Shares Short (prior month ) 4N/A

Dividends & Splits

Forward Annual Dividend Rate 480
Forward Annual Dividend Yield 43.60%
Trailing Annual Dividend Rate 380.00
Trailing Annual Dividend Yield 33.60%
5 Year Average Dividend Yield 42.08
Payout Ratio 430.01%
Dividend Date 3N/A
Ex-Dividend Date 4Sept 27, 2024
Last Split Factor 25:1
Last Split Date 3Mar 29, 2016

Financial Highlights

Fiscal Year

Fiscal Year Ends Mar 31, 2024
Most Recent Quarter (mrq)Mar 31, 2024

Profitability

Profit Margin 25.46%
Operating Margin (ttm)13.90%

Management Effectiveness

Return on Assets (ttm)11.16%
Return on Equity (ttm)16.56%

Income Statement

Revenue (ttm)502.67B
Revenue Per Share (ttm)1,047.21
Quarterly Revenue Growth (yoy)4.30%
Gross Profit (ttm)N/A
EBITDA 178.43B
Net Income Avi to Common (ttm)127.98B
Diluted EPS (ttm)266.52
Quarterly Earnings Growth (yoy)2.10%

Balance Sheet

Total Cash (mrq)204.6B
Total Cash Per Share (mrq)435.64
Total Debt (mrq)8.86B
Total Debt/Equity (mrq)1.11%
Current Ratio (mrq)3.99
Book Value Per Share (mrq)1,688.42

Cash Flow Statement

Operating Cash Flow (ttm)110.66B
Levered Free Cash Flow (ttm)50.1B